James Felker, MD

Trials

Studies that name James Felker, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:34 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT02358187 · A Vaccine Trial for Low Grade Gliomas

  James Felker · recruiting · Low Grade Glioma · principal investigator
• Ph1
  NCT01795313 · Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod

  James Felker · terminated · Ependymoma · principal investigator
• Ph1
  NCT01130077 · A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction with Poly-ICLC in Pediatric Gliomas

  James Felker · completed · Newly Diagnosed Pediatric Pontine Glioma, Newly Diagnosed Pediatric High Grade Glioma, Recurrent Pediatric High Grade Glioma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 19 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Peptide vaccine immunotherapy for children with recurrent low-grade astrocytomas
  R01CA187219 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Ian F. Pollack · fiscal years 2016 to 2020
  Named on NCT02358187
• Peptide vaccine-based immunotherapy for children with recurrent ependymomas.
  R01CA174858 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Ian F. Pollack · fiscal years 2013 to 2015
  Named on NCT01795313